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ABSTRACT 
 
 
Objective: This study was conducted to compare the clinical outcomes between 
amoxicillin/clavulanate plus doxycycline (AC-D) and amoxicillin/clavulanate plus 
azithromycin (AC-A) in cardiovascular disease patients. Methods: This was a 
retrospective medical review study of 282 patients with mild to moderate community 
acquired pneumonia (CAP) admitted in general medical wards, Hospital Sultanah 
Nora Ismail (HSNI) from January 2014 until August 2015. Patients were divided 
equally into two groups based on antibiotics received within the first 48 hours of ward 
admission. Patient demographics, initial laboratory findings, antibiotic therapy, daily 
vital signs and relevant clinical outcomes were extracted from medical records. 
Clinical outcomes were compared between two groups of antibiotics by using 
appropriate statistical tests. Results: Compared to the patients treated with AC-A, 
those treated with AC-D had similar in time to reach clinical stability (2.32 vs. 2.12 
days, p = 0.24), time to switch therapy (3.04 vs. 2.80 days, p = 0.20), hospital LOS 
(3.15 vs. 2.88 days, p = 0.23), rate of treatment failure (1.4% vs. 2.1%, p = 1.00), 
number of patients who developed QT prolongation (0% vs. 0.7%, p = 1.00) and early 
achievement in overall clinical outcomes (64.5% vs. 67.6%, p = 0.58). Conclusions: 
The use of AC-D in cardiovascular disease patients is non-inferior to AC-A. Based on 
these findings, the clinical effectiveness of AC-D should be evaluated prospectively. 
 
 
 
 
 
 
  
vi 
 
TABLE OF CONTENTS 
 
AUTHOR’S DECLARATION III 
ABSTRACT IV 
ACKNOWLEDGEMENT V 
LIST OF TABLES IX 
LIST OF FIGURES X 
LIST OF ABBREVIATIONS XII 
 
 
CHAPTER ONE:  INTRODUCTION 1 
1.1  Background of the Study 1 
1.2  Problem of Statement 2 
1.3  Objective of the Study 3 
1.4  Significance of the Study 3 
 
CHAPTER TWO:  LITERATURE REVIEW 4 
2.1  Definition of Cardiovascular Disease 4 
2.2  Etiology of CAP 4 
2.3  Assessment of Severity of Illness 5 
2.4  Guidelines of CAP Treatment in Adults 8 
            2.4.1  Outpatient Treatment 8 
            2.4.2  Hospitalized, Non-ICU Treatment 8 
            2.4.3  Hospitalized, ICU Treatment 9 
2.5  The Role of Macrolides in CAP Treatment 11 
            2.5.1  Current Prescribing Pattern in Malaysia 11 
            2.5.2  Macrolides and the Risk of Cardiovascular Events 12 
 
 
vii 
 
2.6  Doxycycline as an Empirical Treatment for CAP 13 
            2.6.1  Clinical Outcomes of Doxycycline for CAP Treatment 14 
                       2.6.1.1  Time to Clinical Stability 14 
                       2.6.1.2  Time to Switch Therapy 17 
                       2.6.1.3  Hospital Length of Stay 19 
                       2.6.1.4  Treatment Failure 21 
                       2.6.1.5  Readmission Rate after Hospital Discharged 23 
                       2.6.1.6  Mortality Rate 24 
 
CHAPTER THREE:  RESEARCH METHODOLOGY 27 
3.1  Study Design  27 
3.2  Study Population 27 
3.3  Sample Size Determination 28 
3.4  Data Collection 29 
            3.4.1  Retrieving Patients' Medical Records 29 
            3.4.2  Assessment of Severity of CAP 29 
            3.4.3  Study End Points 30 
            3.4.4  Outcomes Definition 30 
                       3.4.4.1  Time to Clinical Stability 30 
                       3.4.4.2  Time to Switch Therapy 31 
                       3.4.4.3  Hospital Length of Stay 31 
                       3.4.4.4  Treatment Failure 31 
                       3.4.4.5  Overall Clinical Outcomes 31 
3.5  Data Analysis   32 
            3.5.1  Chi-square Test or Fisher's Exact Test 32 
            3.5.2  Student's t-test 32 
 
 
 
